Novartis Beats Generics' Entresto Patent Challenge At EPO
Novartis has persuaded an appeals panel to uphold its European patent covering blockbuster heart disease drug Entresto, fighting off arguments from numerous generics companies that the treatment isn't inventive....To view the full article, register now.
Already a subscriber? Click here to view full article